BIOMAT Database Logo BIOMAT Database Logo

Immunologic evaluation of renal allograft recipients. 1977

J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams

UI MeSH Term Description Entries
D008263 Macrophage Migration-Inhibitory Factors Proteins released by sensitized LYMPHOCYTES and possibly other cells that inhibit the migration of MACROPHAGES away from the release site. The structure and chemical properties may vary with the species and type of releasing cell. Macrophage Migration Inhibitory Factor,Migration Inhibition Factors, Macrophage,Macrophage Migration Inhibition Factors,Migration Inhibition Factor, Macrophage,Macrophage Migration Inhibitory Factors,Migration-Inhibitory Factors, Macrophage
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
Immunologic follow-up renal allograft recipients.
December 1972, Transplantation proceedings,
J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
Immunologic response to cytomegalovirus infection in renal allograft recipients.
December 1969, American journal of epidemiology,
J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
February 1989, Transplantation proceedings,
J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
Immunologic monitoring in lung allograft recipients.
January 1996, Transplantation,
J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
Immunopharmacodynamic evaluation of cyclosporine-treated renal allograft recipients.
December 1984, Transplantation,
J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
Evaluation of flowcytometric crossmatching in renal allograft recipients.
January 1992, Nephron,
J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
Immunologic parameters as predictive factors of cytomegalovirus disease in renal allograft recipients.
July 1999, The Journal of infectious diseases,
J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
The prevalence of immunologic injury in renal allograft recipients with de novo proteinuria.
January 2012, PloS one,
J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
Evaluation of potential renal donors and renal allograft recipients: digital video subtraction angiography.
May 1982, AJR. American journal of roentgenology,
J Cerilli, and J E Holliday, and A Koolemans-Beynen, and D P Fesperman, and M A Williams
Pregnancy in renal allograft recipients.
December 1999, Transplantation proceedings,
Copied contents to your clipboard!